Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Claire Henchcliffe

Claire Henchcliffe

Weill Cornell Medical Center USA

Sergey Suchkov

Sergey Suchkov

I.M. Sechenov First Moscow State Medical University Russia

Tanongsak Panyawirunroj

Tanongsak Panyawirunroj

Asia Cosmetic Hospital Thailand

Jyh-Ping Chen

Jyh-Ping Chen

Chang Gung University Taiwan

Denis Butnaru

Denis Butnaru

Institute for Regenerative Medicine Russia

 Roberta Di Pietro

Roberta Di Pietro

University of Chieti-Pescara Italy

Alina Borkowska

Alina Borkowska

Nicolaus Copernicus University in Torun Poland

Leah Vardy

Leah Vardy

A*STAR Singapore

Tissue Science Congress

Welcome Message

About Conference

Conference LLC invites all the participants from all over the world to attend “8th International Conference on Tissue Science and Regenerative Medicine” during September 11-12, 2017 in Singapore City, Singapore which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Tissue Science and Regenerative Medicine 2017 on behalf of its organizing Committee welcomes all the stem cell technologists, researchers, industrialists, young scientists as well as student and corporate delegates to participate and to have a great experience. The theme of the conference is based on “Explore and Exploit the Novel Techniques to Repair, Restore and Regenerate. International symposiums, B2B meetings, international workshops will also be organized to discuss the specific topics in the field of Stem cell technology during the conference. We also welcome International Exhibitions form corporate sectors to showcase the recent advancements in the tools and techniques.

Why to attend???

With members from around the world focused on learning about Tissue Science and Regenerative Medicine; this is your best opportunity to reach the largest assemblage of participants from the Tissue Science and Regenerative Medicine community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Tissue Science and Regenerative Medicine are hallmarks of this conference.

Target Audience:

  • Tissue Science and Regenerative Medicine Researchers
  • Tissue Science and Regenerative Medicine Faculty
  • Medical Colleges
  • Tissue Science and Regenerative Medicine Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Global Tissue Science and Regenerative Medicine Companies
  • Tissue Science and Regenerative Medicine Investors
  • Exhibitors and Sponsors

Conference Highlights

Sessions/ Tracks

The 8th International Conference on Tissue Science & Regenerative Medicine which is going to be held during September 11-12, 2017 at Singapore will bring together world-class personalities working on stem cells, tissue engineering and regenerative medicine to discuss materials-related strategies for disease remediation and tissue repair.

Tissue Regeneration

In the field of biology, regeneration is the progression of renewal, regeneration and growth that makes it possible for genomes, cells, organ regeneration to natural changes or events that cause damage or disturbance. This study is carried out as craniofacial tissue engineering, in-situ tissue regeneration, adipose-derived stem cells for regenerative medicine which is also a breakthrough in cell culture technology. The study is not stopped with the regeneration of tissue where it is further carried out in relation with cell signaling, morphogenetic proteins. Most of the neurological disorders occurred accidental having a scope of recovery by replacement or repair of intervertebral discs repair, spinal fusion and many more advancements. The global market for tissue engineering and regeneration products such as scaffolds, tissue implants, biomimetic materials reached $55.9 billion in 2010 and it is expected to reach $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.  It grows to $135 billion by 2024.

Related Conferences

8th International Conference on Tissue Science and Regenerative Medicine August 07-09, 2017 Auckland, New Zealand; 6th International Conference on Cell and Gene Therapy Mar 2-3, 2017 Madrid, Spain; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 13th European Cardiology Conference December 05-06, 2016 Madrid, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA ;9th Annual Conference on Stem Cell and Regenerative Medicine Sep 05-06, 2017 Paris, France; International Conference on Restorative & Alternative Medicine October 24-25, 2016 Chicago, Illinois, USA; 3rd International Conference & Exhibition on Tissue Preservation and Biobanking August 23-24, 2017 San Francisco, USA; 2nd Annual Conference and Expo on Biomaterials March 27-28, 2017 Madrid, Spain; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 2nd World Congress on Connective Tissue Diseases Sep 27-29, 2017 Chicago, USA; International Conference on Cell Signalling and Cancer Therapy Aug 20-22, 2017 Paris, France; 14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA

 

Designs for Tissue Engineering

The developing field of tissue engineering aims to regenerate damaged tissues by combining cells from the body with bioresorbable materials, biodegradable hydrogel, biomimetic materials, nanostructures and nanomaterials, biomaterials and tissue implants which act as templates for tissue regeneration, to guide the growth of new tissue by using with the technologies. The global market for biomaterials, nanostructures and bioresorbable materials are estimated to reach $88.4 billion by 2017 from $44.0 billion in 2012 growing at a CAGR of 15%. Further the biomaterials market estimated to be worth more than 300 billion US Dollars and to be increasing 20% per year.

Related Conferences

Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 2nd World Congress on Connective Tissue Diseases Sep 27-29, 2017 Chicago, USA; International Conference on Cell Signalling and Cancer Therapy Aug 20-22, 2017 Paris, France; 14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA; 7th International Conference on Tissue Engineering and Regenerative Medicine October 02-04, 2017 Barcelona, Spain; 6th International Conference on Cell and Gene Therapy Mar 2-3, 2017 Madrid, Spain; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 13th European Cardiology Conference December 05-06, 2016 Madrid, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA

 

Organ Engineering

This interdisciplinary engineering has attracted much attention as a new therapeutic means that may overcome the drawbacks involved in the current artificial organs and organ transplantation that have been also aiming at replacing lost or severely damaged tissues or organs. Tissue engineering and regenerative medicine is an exciting research area that aims at regenerative alternatives to harvested tissues for organ transplantation with soft tissues. Although significant progress has been made in the tissue engineering field, many challenges remain and further development in this area will require ongoing interactions and collaborations among the scientists from multiple disciplines, and in partnership with the regulatory and the funding agencies. As a result of the medical and market potential, there is significant academic and corporate interest in this technology.

Related Conferences

8th International Conference on Tissue Science and Regenerative Medicine August 07-09, 2017 Auckland, New Zealand; 6th International Conference on Cell and Gene Therapy Mar 2-3, 2017 Madrid, Spain; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 13th European Cardiology Conference December 05-06, 2016 Madrid, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 2nd World Congress on Connective Tissue Diseases Sep 27-29, 2017 Chicago, USA; International Conference on Cell Signalling and Cancer Therapy Aug 20-22, 2017 Paris, France; 14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA

 

Cancer Stem Cells

The characterization of cancer stem cell is done by identifying the cell within a tumor that possesses the capacity to self-renew and to cause the heterogeneous lineages of cancer cells that comprise the tumor. This stem cell which acts as precursor for the cancer acts as a tool against it indulging the reconstruction of cancer stem cells, implies as the therapeutic implications and challenging the gaps globally. The global stem cell market will grow from about $5.6 billion in 2013 to nearly $10.6 billion in 2018, registering a compound annual growth rate (CAGR) of 3.6% from 2013 through 2018. The Americas is the largest region of global stem cell market, with a market share of about $2.0 billion in 2013. The region is projected to increase to nearly $3.9 billion by 2018, with a CAGR of 13.9% for the period of 2013 to 2018. Europe is the second largest segment of the global stem cell market and is expected to grow at a CAGR of 13.4% reaching about $2.4 billion by 2018 from nearly $1.4 billion in 2013.

Related Conferences

8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA ;9th Annual Conference on Stem Cell and Regenerative Medicine Sep 05-06, 2017 Paris, France; International Conference on Restorative & Alternative Medicine October 24-25, 2016 Chicago, Illinois, USA; 3rd International Conference & Exhibition on Tissue Preservation and Biobanking August 23-24, 2017 San Francisco, USA; Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 7th International Conference on Tissue Engineering and Regenerative Medicine October 02-04, 2017 Barcelona, Spain; 6th International Conference on Cell and Gene Therapy Mar 2-3, 2017 Madrid, Spain; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 13th European Cardiology ConferenceDecember 05-06, 2016 Madrid, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; 2nd World Congress on Connective Tissue Diseases Sep 27-29, 2017 Chicago, USA; International Conference on Cell Signalling and Cancer Therapy Aug 20-22, 2017 Paris, France; 14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA

 

Bone Tissue Engineering

Tissue engineering of musculoskeletal tissues, particularly bone and cartilage, is a rapidly advancing field. In bone, technology has centered on bone graft substitute materials and the development of biodegradable scaffolds. Recently, tissue engineering strategies have included cell and gene therapy. The availability of growth factors and the expanding knowledge base concerning the bone regeneration with modern techniques like recombinant signaling molecules, solid free form fabrication of scaffolds, synthetic cartilage, Electrochemical deposition, spinal fusion and ossification are new generated techniques for tissue-engineering applications. The worldwide market for bone and cartilage repairs strategies is estimated about $300 million. During the last 10/15 years, the scientific community witnessed and reported the appearance of several sources of stem cells with both osteo and chondrogenic potential.

Related Conferences

8th International Conference on Tissue Science and Regenerative Medicine August 07-09, 2017 Auckland, New Zealand; 6th International Conference on Cell and Gene Therapy Mar 2-3, 2017 Madrid, Spain; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 13th European Cardiology Conference December 05-06, 2016 Madrid, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA;Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 2nd World Congress on Connective Tissue Diseases Sep 27-29, 2017 Chicago, USA; International Conference on Cell Signalling and Cancer Therapy Aug 20-22, 2017 Paris, France; 14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA ;9th Annual Conference on Stem Cell and Regenerative Medicine Sep 05-06, 2017 Paris, France; International Conference on Restorative & Alternative MedicineOctober 24-25, 2016 Chicago, Illinois, USA; 3rd International Conference & Exhibition on Tissue Preservation and Biobanking August 23-24, 2017 San Francisco, USA

 

Scaffolds

Scaffolds are one of the three most important elements constituting the basic concept of regenerative medicine, and are included in the core technology of regenerative medicine. Every day thousands of surgical procedures are performed to replace or repair tissue that has been damaged through disease or trauma. The developing field of tissue engineering (TE) aims to regenerate damaged tissues by combining cells from the body with highly porous scaffold biomaterials, which act as templates for tissue regeneration, to guide the growth of new tissue. Scaffolds has a prominent role in tissue regeneration the designs, fabrication, 3D models, surface ligands and molecular architecture, nanoparticle-cell interactions and porous of the scaffolds are been used in the field in attempts to regenerate different tissues and organs in the body. The world stem cell market was approximately 2.715 billion dollars in 2010, and with a growth rate of 16.8% annually, a market of 6.877 billion dollars will be formed in 2016. From 2017, the expected annual growth rate is 10.6%, which would expand the market to 11.38 billion dollars by 2021.

Related Conferences

Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 2nd World Congress on Connective Tissue Diseases Sep 27-29, 2017 Chicago, USA; International Conference on Cell Signalling and Cancer Therapy Aug 20-22, 2017 Paris, France; 14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA ;9th Annual Conference on Stem Cell and Regenerative Medicine Sep 05-06, 2017 Paris, France; International Conference on Restorative & Alternative Medicine October 24-25, 2016 Chicago, Illinois, USA; 3rd International Conference & Exhibition on Tissue Preservation and Biobanking August 23-24, 2017 San Francisco, USA; 7th International Conference on Tissue Engineering and Regenerative Medicine October 02-04, 2017 Barcelona, Spain; 6th International Conference on Cell and Gene Therapy Mar 2-3, 2017 Madrid, Spain; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 13th European Cardiology Conference December 05-06, 2016 Madrid, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA

 

Tissue Regeneration Technologies

Guided tissue regeneration is defined as procedures attempting to regenerate lost periodontal structures through differential tissue responses. Guided bone regeneration typically refers to ridge augmentation or bone regenerative procedures it typically refers to regeneration of periodontal therapy. The recent advancements and innovations in biomedical and regenerative tissue engineering techniques include the novel approach of guided tissue regeneration and combination of nanotechnology and regenerative medicine. 

Related Conferences

Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 2nd World Congress on Connective Tissue Diseases Sep 27-29, 2017 Chicago, USA; International Conference on Cell Signalling and Cancer Therapy Aug 20-22, 2017 Paris, France; 14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA; 7th International Conference on Tissue Engineering and Regenerative Medicine October 02-04, 2017 Barcelona, Spain; 6th International Conference on Cell and Gene Therapy Mar 2-3, 2017 Madrid, Spain; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA ;9th Annual Conference on Stem Cell and Regenerative Medicine Sep 05-06, 2017 Paris, France; International Conference on Restorative & Alternative Medicine October 24-25, 2016 Chicago, Illinois, USA; 3rd International Conference & Exhibition on Tissue Preservation and Biobanking August 23-24, 2017 San Francisco, USA; 13th European Cardiology Conference December 05-06, 2016 Madrid, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA

 

Regeneration and Therapeutics

Regenerative medicine can be defined as a therapeutic intervention which replaces or regenerates human cells, tissues or organs, to restore or establish normal function and deploys small molecule drugs, biologics, medical devices and cell-based therapies. It deals with the different therapeutic uses like stem cells for tissue repair, tissue injury and healing process, cardiac stem cell therapy for regeneration, functional regenerative recovery, effects of aging on tissue repair/regeneration, corneal regeneration & degeneration. The global market is expected to reach $25.5 billion by 2011 and will further grow to $36.1 billion by 2016 at a CAGR of 7.2%. It is expected to reach $65 billion mark by 2024.

Related Conferences

8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA ;9th Annual Conference on Stem Cell and Regenerative Medicine Sep 05-06, 2017 Paris, France; International Conference on Restorative & Alternative Medicine October 24-25, 2016 Chicago, Illinois, USA; 3rd International Conference & Exhibition on Tissue Preservation and Biobanking August 23-24, 2017 San Francisco, USA; Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 2nd World Congress on Connective Tissue Diseases Sep 27-29, 2017 Chicago, USA; 7th International Conference on Tissue Engineering and Regenerative Medicine October 02-04, 2017 Barcelona, Spain; 6th International Conference on Cell and Gene Therapy Mar 2-3, 2017 Madrid, Spain; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 13th European Cardiology Conference December 05-06, 2016 Madrid, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA;International Conference on Cell Signalling and Cancer Therapy Aug 20-22, 2017 Paris, France; 14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA

 

Regenerative medicine

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function. The latest developments involve advances in cell and gene therapy and stem cell research, molecular therapy, dental and craniofacial regeneration. Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of restoring the functionality of cells and tissues. The global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during forecast period (2014 - 2020). Small molecules and biologics segment holds prominent market share in the overall regenerative medicine technology market and is anticipated to grow at a CAGR of 18.9% during the forecast period.

Related Conferences

Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 2nd World Congress on Connective Tissue Diseases Sep 27-29, 2017 Chicago, USA; International Conference on Cell Signalling and Cancer Therapy Aug 20-22, 2017 Paris, France; 7th International Conference on Tissue Engineering and Regenerative Medicine October 02-04, 2017 Barcelona, Spain; 6th International Conference on Cell and Gene Therapy Mar 2-3, 2017 Madrid, Spain; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA ;9th Annual Conference on Stem Cell and Regenerative Medicine Sep 05-06, 2017 Paris, France; International Conference on Restorative & Alternative Medicine October 24-25, 2016 Chicago, Illinois, USA; 3rd International Conference & Exhibition on Tissue Preservation and Biobanking August 23-24, 2017 San Francisco, USA;  2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 13th European Cardiology Conference December 05-06, 2016 Madrid, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 8th World Congress onMolecular Pathology June 26-28, 2017 San Diego, USA;14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA

 

Applications of Tissue Engineering

The applications of tissue engineering and regenerative medicine are innumerable as they mark the replacement of medication and organ replacement. The applications involve cell tracking and tissue imaging, cell therapy and regenerative medicine, organ harvesting, transport and transplant, the application of nanotechnology in tissue engineering and regenerative medicine and bio banking. Globally the research statistics are increasing at a vast scale and many universities and companies are conducting events on the subject regenerative medicine conference like tissue implants workshops, endodontic meetings, tissue biomarkers events, tissue repair meetings, regenerative medicine conferencestissue engineering conference, regenerative medicine workshop, veterinary regenerative medicine, regenerative medicine symposiums, tissue regeneration conferences, regenerative medicine congress.

Related Conferences

Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 2nd World Congress on Connective Tissue Diseases Sep 27-29, 2017 Chicago, USA; International Conference on Cell Signalling and Cancer Therapy Aug 20-22, 2017 Paris, France; 14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA; 7th International Conference on Tissue Engineering and Regenerative Medicine October 02-04, 2017 Barcelona, Spain; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA ;9th Annual Conference on Stem Cell and Regenerative Medicine Sep 05-06, 2017 Paris, France; International Conference on Restorative & Alternative Medicine October 24-25, 2016 Chicago, Illinois, USA; 3rd International Conference & Exhibition on Tissue Preservation and Biobanking August 23-24, 2017 San Francisco, USA; 6th International Conference on Cell and Gene Therapy Mar 2-3, 2017 Madrid, Spain; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 13th European Cardiology Conference December 05-06, 2016 Madrid, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA

 

Regenerative Medicine Market

There are strong pricing pressures from public healthcare payers globally as Governments try to reduce budget deficits. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole. The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.  It grows to $135 billion to 2024. The contribution of the European region was 43.3% of the market in 2010, a value of $24.2 billion. The market is expected to reach $25.5 billion by 2011 and will further grow to $36.1 billion by 2016 at a CAGR of 7.2%. It grows to $65 billion to 2024.

Related Conferences

Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 7th International Conference on Tissue Engineering and Regenerative Medicine October 02-04, 2017 Barcelona, Spain; 6th International Conference on Cell and Gene Therapy Mar 2-3, 2017 Madrid, Spain; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 13th European Cardiology Conference December 05-06, 2016 Madrid, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; 2nd World Congress on Connective Tissue Diseases Sep 27-29, 2017 Chicago, USA; International Conference on Cell Signalling and Cancer Therapy Aug 20-22, 2017 Paris, France; 14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA ;9th Annual Conference on Stem Cell and Regenerative Medicine Sep 05-06, 2017 Paris, France; International Conference on Restorative & Alternative MedicineOctober 24-25, 2016 Chicago, Illinois, USA; 3rd International Conference & Exhibition on Tissue Preservation and Biobanking August 23-24, 2017 San Francisco, USA

 

Embryonic Stem Cell

Embryonic stem cells are pluripotent, meaning they are able to grow (i.e. differentiate) into all derivatives of the three primary germ layers: ectoderm, endoderm and mesoderm. In other words, they can develop into each of the more than 200 cell types of the adult body as long as they are specified to do so. Embryonic stem cells are distinguished by two distinctive properties: their pluripotency, and their ability to replicate indefinitely. ES cells are pluripotent, that is, they are able to differentiate into all derivatives of the three primary germ layers: ectoderm, endoderm, and mesoderm. These include each of the more than 220 cell types in the adult body. Pluripotency distinguishes embryonic stem cells from adult stem cells found in adults; while embryonic stem cells can generate all cell types in the body, adult stem cells are multipotent and can produce only a limited number of cell types. Additionally, under defined conditions, embryonic stem cells are capable of propagating themselves indefinitely. This allows embryonic stem cells to be employed as useful tools for both research and regenerative medicine, because they can produce limitless numbers of themselves for continued research or clinical use.

Related Conferences

8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA ;9th Annual Conference on Stem Cell and Regenerative Medicine Sep 05-06, 2017 Paris, France; International Conference on Restorative & Alternative Medicine October 24-25, 2016 Chicago, Illinois, USA; 3rd International Conference & Exhibition on Tissue Preservation and Biobanking August 23-24, 2017 San Francisco, USA; Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 7th International Conference on Tissue Engineering and Regenerative Medicine October 02-04, 2017 Barcelona, Spain; 6th International Conference on Cell and Gene Therapy Mar 2-3, 2017 Madrid, Spain; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 13th European Cardiology Conference December 05-06, 2016 Madrid, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; 2nd World Congress on Connective Tissue Diseases Sep 27-29, 2017 Chicago, USA; International Conference on Cell Signaling and Cancer Therapy Aug 20-22, 2017 Paris, France; 14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA

 

Stem Cell Transplant

Stem cell transplantation is a procedure that is most often recommended as a treatment option for people with leukemia, multiple myeloma, and some types of lymphoma. It may also be used to treat some genetic diseases that involve the blood. During a stem cell transplant diseased bone marrow (the spongy, fatty tissue found inside larger bones) is destroyed with chemotherapy and/or radiation therapy and then replaced with highly specialized stem cells that develop into healthy bone marrow. Although this procedure used to be referred to as a bone marrow transplant, today it is more commonly called a stem cell transplant because it is stem cells in the blood that are typically being transplanted, not the actual bone marrow tissue.

Related Conferences

8th International Conference on Tissue Science and Regenerative Medicine August 07-09, 2017 Auckland, New Zealand; Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 2nd World Congress on Connective Tissue Diseases Sep 27-29, 2017 Chicago, USA; 7th International Conference on Tissue Engineering and Regenerative Medicine October 02-04, 2017 Barcelona, Spain; 6th International Conference on Cell and Gene Therapy Mar 2-3, 2017 Madrid, Spain; 2nd International Conference on Tumor & Cancer Immunology and Immunotherapy July 17-19, 2017 Chicago, USA; 13th European Cardiology Conference December 05-06, 2016 Madrid, Spain; International Conference on Molecular Biology October 13-15, 2016 Dubai, UAE; 8th World Congress on Molecular Pathology June 26-28, 2017 San Diego, USA; International Conference on Cell Signalling and Cancer Therapy Aug 20-22, 2017 Paris, France; 14th International Conference on Clinical & Experimental Cardiology November 14-16, 2016 Orlando, Florida, USA.

 

Market Analysis

Market Analysis Report:

Tissue Engineering is a process involving in-vitro development of tissues or organs. It is done to replace or support the function of defective or injured body part. Tissue engineering involves the application of biology and engineering for innovation of tissue substitutes that can maintain, restore and improve the function of ruptured human tissue. Products developed by this procedure are efficient and durable.  Tissue engineering is gaining its popularity in various areas such as burn treatment or wound care, neurology products, orthopaedics, urological products and others. On the basis of type of material used, tissue engineering and regeneration market can be segmented into synthetic, genetically modified and biological materials. In terms of technology, tissue engineering and regeneration market can be segmented into immunoisolation technology, cell culture technology and stem cell technology.

On the basis of its applications, orthopedic and dermal sections have the largest market in tissue engineering and regeneration market. North America dominates the global market for tissue engineering and regeneration due to large number of aging people and increasing desire for such surgeries in the region. Europe is expected to experience less growth rate as compared to Asia. This is due to more stringent laws and regulations present in the region. Asia is expected to experience high growth rate in global tissue engineering and regeneration market. Some of the key driving forces for growth of tissue engineering and regeneration market in emerging countries are increasing pool of patients and increasing awareness in these regions. 

Rising cost of organ transplantation and increasing medical applications of 3D printing in tissue and organ regeneration are driving the global tissue engineering and regeneration market. In addition, this technology is gaining popularity due to its efficient products and reduced rejection rates. Varied applications of this technology, for instance, its wound care followed by orthopedics applications has been driving this market at a high growth rate. Dental and neurologic applications are also expected to drive tissue engineering and regeneration market in near future. Globally, number of regeneration surgeries performed is increasing every year. According to Clear point Medical, which is involved in designing, manufacturing and distribution of compression wear, in 2013, in the U.S., number of reconstruction procedures performed increased by 2% from that in year 2012 and reached a number of about 5.6 million. However, due to slow development, high costs involved in procedure and increasing biological complexity of tissue engineering and regeneration procedures, the global tissue engineering and regeneration market is expected to impede. 

Statistics which shows growth of Tissue Engineering and Regenerative Medicine:

Recent developments in the field of regeneration surgeries, particularly stem cell research, is expected to offer new opportunities for global tissue engineering and regeneration market. Big companies dealing in the market have been involved in partnerships, mergers and acquisitions with smaller companies.  This is one the major trends observed in the global tissue engineering and regeneration market. In addition, companies are focusing on approval and patents for their products.

USA: Regenerative medicines market by therapy (cell therapy, gene therapy, immunotherapy, tissue engineering), region - global forecast to 2021, the global regenerative medicines market size is expected to reach USD 49.41 billion by 2021,. North America contributed the largest share in the global regenerative medicines market, and was dominated largely by the U.S.

Europe: The global tissue engineering and regeneration market reached $17 billion in 2013. This market is expected to grow to nearly $20.8 billion in 2014 and $56.9 billion in 2019, Today, there are 640  privately held and  publicly traded companies  in Europe, Japan, and the U.S.

Middle East: Middle East and Africa regenerative medicines market is expected to reach USD 5.75 billion by 2021 from USD 2.03 billion in 2016, growing at a CAGR of 23.15% during the forecast period 2016-2021. Regenerative medicines repair, replace or regenerate human cells, tissues, or organs affected due to injury, disease, aging processes, congenital defects, and damage due to trauma.

Asia Pacific: Asia-Pacific regenerative medicines market is expected to reach USD 10.71 billion by 2021 from USD 3.01 billion in 2016, growing at a CAGR of 28.90% during the forecast period 2016-2021.  cell-based products segment is estimated to account for larger share of Asia-Pacific regenerative medicines market by product in 2016.

Highlights:

·                 Tissue Engineering: Progress and Prospects

·                 Tissue Repair and Regeneration

·                 Stem Cells: The Tissue Engineering Approach

·                 Regenerative Medicine

·                 Stem Cell Transplantation

·                 Scaffolds and Biomaterials for Tissue Engineering

·                 Translational Medicine

·                 Stem Cell Therapy

·                 Cell Based Therapy

·                 Gene Therapy

·                 Bone and Cartilage Tissue Engineering

·                 Rejuvenation- Fight Aging

·                 Cell and Organ Regeneration

·                 Regenerative Medicine Market

Why to attend???

Meet Your Target Market With members from around the world focused on learning about Advertising and marketing, this is the single best opportunity to reach the largest assemblage of participants from the tissue engineering and regenerative medicine community. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Tissue Regeneration, Materials & Designs for Tissue Engineering, Stem Cell–Tools to Battle Cancer, Bioreactors in Tissue Engineering, Regeneration & Therapeutics, Cord Blood & Regenerative Medicine and Clinical Medicine, to mention a few. The three days event implants a firm relation of upcoming strategies in the field of Tissue Engineering & Regenerative Medicine with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations. Conduct demonstrations, distribute information, meet with current and potential customers, make a splash with a new product line, and receive name recognition.

Major Regenerative Medicine and Tissue Engineering Associations around the Globe

International Stem Cell Forum (ISCF)

International Society for Stem Cell Research (ISSCR)

UK Medical Research Council (MRC)

Australian Stem Cell Center

Canadian Institutes of Health Research (CIHR)

Euro Stem Cell (ACR)

Center for Stem Cell Biology

Stem Cell Research Singapore

UK National Stem Cell Network

Target Audience:

Presidents or Vice Presidents/ Directors of Associations and Societies, CEO’s of the companies associated with regenerative medicine and tissue engineering Consumer Products. Retailers, Marketing, Advertising and Promotion Agency Executives, Solution Providers (digital and mobile technology, P-O-P design, retail design, and retail execution), Professors and Students from Academia in the study of Marketing and Advertising filed.

Target Audience:

Industry        40%

Academia     50%

Others          10%

 

Glance at Market of Regenerative Medicine and Tissue Engineering:

There are strong pricing pressures from public healthcare payers globally as Governments try to reduce budget deficits. Regenerative medicine could potentially save public health bodies money by reducing the need for long-term care and reducing associated disorders, with potential benefits for the world economy as a whole. The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.  It grows to $135 billion to 2024.

Past Conference Report

Regenerative Medicine 2016

5th International Conference on Tissue Engineering and Regenerative Medicine was organized during September 12-14, 2016 at Berlin, Germany. The conference was marked with the attendance of Editorial Board Members of supporting journals, Scientists, young and brilliant researchers, business delegates and talented student communities representing more than 25 countries, who made this conference fruitful and productive.

This conference was based on the theme “Advanced Approaches In Stem Cell and Regenerative Medicine” which included the following scientific tracks: 

  • Translational Medicine
  • Bone Tissue Engineering
  • Models of Regeneration
  • Regenerative Medicine
  • Scaffolds in Regenerative Medicine
  • Stem Cells
  • Tissue Repair and Regeneration
  • Rejuvenation
  • Cell Engineering
  • Tissue Engineering
  • Cell and Organ Regeneration
  • Regenerative Medicine Market
  • Stem Cell Treatments
  • Cellular Therapies
  • Gene Therapies
  • Immunotherapy
  • Biomaterials and Bioengineering
  • Stem Cell Transplant
  • Ethical and Legal Issues
  • Embryonic Stem Cell
  • Regenerative Medicine Europe

The Organizing Committee would like to thank the moderator Dr. Nilanjana Maulik (University of Connecticut, USA) for her contribution which resulted in smooth functioning of the conference.

The conference proceeded through various scientific sessions and plenary lectures, of which the following topics were highlighted as Keynote presentations:

Barritault Denis - The importance of extra cellular matrix organization and the use of RGTA technology in regenerative Medicine (OTR3, France)

Y James Kang -Rejuvenation therapy for ischemic heart disease(Sichuan University, China)

Taihua Wang- Significant physical function improvements of 3 serious injured patients after neural stem cell therapy (Interventional Hospital of Shandong Red Cross Society and Cell Biotechnology Co. Ltd, China)

Gang Zhang- Using ‘Mouse Clone Model’ to open the door for human iPSC therapy (Interventional Hospital of Shandong Red Cross Society and Cell Biotechnology Co. Ltd, China)

Pedro Morouço - A novel regenerative medicine approach to reconstruct the temporomandibular joint disk (Centro Empresarial da Marinha Grande, Portugal)

Various sessions were chaired and co-chaired by: Barritault Denis-OTR3, France; Hazem Barmada- Mississippi Stem cell Treatment Center, USA; Serban San-Marina- Mayo Clinic, USA; Raphael Gorodetsky- Hadassah-Hebrew University Medical Center, Israel

Conference Series LLC has taken the privilege of felicitating Regenerative Medicine -2016 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this conference.

The esteemed guests, keynote speakers and researchers shared their innovative research and vast experience through their informative presentations at the podium of Regenerative Medicine 2016. We are glad to inform that all accepted abstracts for the conference have been published in Journal of Stem Cell Research & Therapy: Open Access as a special issue.

We are also obliged to various experts, company representatives and other eminent scientists who supported the conference by facilitating the discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support, and assistance. With the unique feedback from the conference, Conference Series LLC would like to proudly announce the commencement of the “8th International Conference on Tissue Science and Regenerative Medicine" to be organized during August 07-09, 2017 at Auckland, New Zealand.

 Let us meet again @ Tissue Science and Regenerative Medicine 2017


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date September 11-12, 2017

Speaker Opportunity

Supported By

Journal of Tissue Science & Engineering Journal of Stem Cell Research & Therapy Journal of Transplantation Technologies & Research

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by